Correlation Between Recursion Pharmaceuticals and Relay Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Relay Therapeutics, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Relay Therapeutics.

Diversification Opportunities for Recursion Pharmaceuticals and Relay Therapeutics

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Recursion and Relay is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Relay Therapeutics go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Relay Therapeutics

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 1.72 times more return on investment than Relay Therapeutics. However, Recursion Pharmaceuticals is 1.72 times more volatile than Relay Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.27 per unit of risk. If you would invest  632.00  in Recursion Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  75.00  from holding Recursion Pharmaceuticals or generate 11.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  Relay Therapeutics

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Relay Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relay Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Recursion Pharmaceuticals and Relay Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and Relay Therapeutics

The main advantage of trading using opposite Recursion Pharmaceuticals and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.
The idea behind Recursion Pharmaceuticals and Relay Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings